Home-mixed product has no such trail
Rev Endocr Metab Disord 25(1):215237
Because BPC-157 lacks robust human safety data across the proposed routes of administration, the FDA states it does not have enough information to know whether compounded BPC-157 would cause harm in humans
Pharmacol Ther 85:1128 Scordo MG, Spina E, Dahl ML, Gatti G, Perrucca E (2005) Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine
Moreover, lifestyle factors such as sedentary behavior can contribute to this condition
4.2 Galectin-3 Galectin-3, a regulatory -galactoside-binding lectin, plays a central role in chronic inflammation, fibrosis, and tissue remodeling, making it a critical biomarker across a spectrum of cardio-renal-hepatic-metabolic disorders (132, 133)